Designing and executing an Early Access Program (EAP) can be a game-changer for emerging life science tools companies—but it comes with challenges. In this candid session, founders and industry experts share real-world lessons from the front lines of launching EAPs. Learn what works, what doesn’t, and how to navigate operational and customer engagement hurdles. Walk away with practical strategies to design an effective EAP that drives validation, builds traction, and prepares you for a successful commercial launch.

Speakers:

• Mark Atlas, CEO, JBC Associates
• Daniel Meyer, CEO of CellChorus
• Scot Weinberger, President, CEO GenNext Technologies